iSelect Fund
VC Fund
St Louis, United States
iSelect Fund is a VC fund in St Louis focused on Biotechnology and Health Care. From spiraling healthcare costs, to the rise of chronic diseases, to feeding a growing global population, the world is facing a complex web of interrelated challenges. iSelect was created to help solve these problems, connecting investors with the innovative companies that are fixing the food and health systems while opening up access to investmentopportunities that are making a real impact on the future of our world.
- Total investments:
- 96
- Last investment:
- Lead investor:
- 15%
- Fund size:
- $3.8M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries iSelect Fund invests in
Stages iSelect Fund invests in
Countries iSelect Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $100k–$10M
- Series A
- $3.3M–$41M
- Series B
- $8.3M–$68M
Investment Focus
Industry
- Biotechnology 25 (26%)
- Health Care 17 (18%)
- Agriculture 16 (17%)
- Software 14 (15%)
- AgTech 13 (14%)
Stage
- Seed 20 (21%)
- Series A 18 (19%)
- Series B 14 (15%)
- Funding Round 10 (10%)
- Venture - Series Unknown 6 (6%)
Country
- United States 54 (56%)
- Canada 2 (2%)
- Australia 1 (1%)
- New Zealand 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ken Harrington
Selection Committee
|
Selection Committee | Total investments: 0 | Find email | |
Bobby Sandage
Member of Selection Committee
|
Member of Selection Committee | Total investments: 2 | Find email | |
Carter Williams
CEO and Managing Director
|
CEO and Managing Director | Total investments: 9 | Find email | |
Craig Herron
Managing Director
|
Managing Director | Total investments: 40 | Find email | |
Dan Schaub
COO
|
COO | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Miraterra
|
Miraterra's solution produces lab-quality findings in soil labs, the field, and the ground. Miraterra's accurate measurements, advanced reporting, and verification technologies will enable a new era of precision agriculture and carbon market credibility. | $11.6M / Seed / Mar 25, 2026 | |
Vive Crop Protection
|
Vive Crop Protection makes effective and sustainable pesticides for organic and non-organic production. The company creates new ways to use proven crop protection products using their targeted Allosperse Delivery System, which improves the targeting and performance of pesticide active ingredients. This helps farmers do more with less, all whileincreasing crop quality and yields.Vive Crop Protection was founded in 2006 and is headquartered in Mississauga, Ontario, Canada. | $10M / Venture - Series Unknown / Oct 07, 2025 | |
Mercy BioAnalytics
|
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018. | $59M / Series B / Sep 03, 2025 | |
Geltor
|
Biodesigned proteins for beauty, wellness and beyond. | Venture - Series Unknown / Aug 07, 2025 | |
|
Geltor
|
Biodesigned proteins for beauty, wellness and beyond. | Venture - Series Unknown / Aug 07, 2025 | |
Growers Edge
|
Growers Edge offers financial products and data-driven tools designed for agricultural retailers and manufacturers. The company focuses on providing solutions that enhance risk management and facilitate the adoption of new technologies in farming practices. By leveraging data science, Growers Edge helps its clients optimize their operations andimprove service delivery to growers. The platform aims to create a comprehensive fintech environment tailored specifically for the agricultural sector, addressing the unique challenges faced by its users. Through these offerings, Growers Edge supports the growth and efficiency of agricultural businesses. | $29.2M / Venture - Series Unknown / Apr 29, 2025 | |
BioLumic
|
BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements incrops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013. | $8.3M / Series B / Apr 22, 2025 | |
Edacious
|
Edacious is a Public Benefit Corporation that develops a radical transparency-based food verification system. | $8.1M / Seed / Feb 06, 2025 | |
one.bio
|
BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States. | $27M / Series A / Dec 12, 2024 | |
EarthOptics
|
GroundTruth Ag is a soil cloud creator specializing in sustainable agricultural management. GroundTruth offers insights into soil management and health as well as near-real-time actionable data layers that cover the physical, chemical, and biological characteristics of the soil. This technology allows farmers to obtain accurate soil informationwhile also offering carbon creditors low-cost, hyper-accurate verification. | $24M / Venture - Series Unknown / Nov 19, 2024 | |
| See all 96 investments → | |||
Co-Investors
Argonautic Ventures
18 deals together
S2G Investments
17 deals together
Cultivation Capital
8 deals together
Alexandria Venture Investments
7 deals together
BioGenerator
7 deals together
Collaborative Fund
7 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does iSelect Fund invest in?
iSelect Fund invests primarily in Biotechnology, Health Care and Agriculture startups, most often at Seed and Series A stage. Most of the 96 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is iSelect Fund's check size?
iSelect Fund typically joins rounds of $100k–$10M at Seed, $3.3M–$41M at Series A and $8.3M–$68M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds iSelect Fund participates in.
How do I contact iSelect Fund?
Public channels for iSelect Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at iSelect Fund?
The team at iSelect Fund includes Ken Harrington (Selection Committee), Bobby Sandage (Member of Selection Committee) and Carter Williams (CEO and Managing Director), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
